Want to see TSE:XCX full AI Analyst Report?
Greenrise Global Brands Inc (XCX) AI Stock Analysis
Greenrise Global Brands Inc
(CNQX:XCX)
Score driven by critical financial weaknesses including zero revenue, deepening negative equity, and high leverage risks; lack of technical data and negative valuation metrics reinforce high-risk profile.
Greenrise Global Brands Inc (XCX) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 258.28K
- Dividend Yield
- ―
- Average Volume (3M)
- 1,050
- Price to Earnings (P/E)
- -1.0
- Beta (1Y)
- 0.50
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Canada
- Employees
- 250
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Greenrise Global Brands Inc Business Overview & Revenue Model
Company Description
Greenrise Global Brands Inc., operating through its various subsidiaries, serves as a pharmaceutical distributor, providing medical cannabis products to pharmacies throughout Germany. The company also offers a broad selection of CBD-infused items, su...
Greenrise Global Brands Inc Financial Statement Overview
Summary
Scores of 15, 12, and 18 for income statement, balance sheet, and cash flow reflect zero revenue, persistent losses, negative equity, high leverage, and volatile cash flows signaling severe financial distress.
Income Statement
15Very NegativeBalance Sheet
12Very NegativeCash Flow
18Very Negative| Breakdown | TTM | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 452.87K | 105.20K |
| Gross Profit | 0 | 0 | 0 | 0 | 43.32K | -153 |
| EBITDA | -597.32K | -542.80K | -120.16K | -752.81K | -2.60M | -2.06M |
| Net Income | -807.54K | -722.06K | -298.91K | -2.32M | -3.64M | -2.11M |
Balance Sheet | ||||||
| Total Assets | 1,305 | 93.53K | 441.82K | 1.25M | 252.94K | 371.56K |
| Cash, Cash Equivalents and Short-Term Investments | 1,305 | 13.53K | 31.53K | -619.68K | 27.45K | 60.45K |
| Total Debt | 2.73M | 2.62M | 2.80M | 3.15M | 1.90M | 1.08M |
| Total Liabilities | 2.88M | 2.79M | 3.06M | 3.56M | 2.26M | 1.34M |
| Stockholders Equity | -2.88M | -2.70M | -2.61M | -2.32M | -2.00M | -972.61K |
Cash Flow | ||||||
| Free Cash Flow | -87.44K | -176.13K | 199.35K | -1.08M | -1.95M | -1.88M |
| Operating Cash Flow | -87.44K | -176.13K | 199.35K | -1.08M | -1.89M | -1.83M |
| Investing Cash Flow | 87.90K | 60.40K | 387.50K | -531.00K | -63.15K | 45.43K |
| Financing Cash Flow | -16.43K | 97.73K | -534.73K | 1.51M | 1.92M | 1.63M |
Greenrise Global Brands Inc Peers Comparison
Overall Rating
TSE:XBRA48.75Neutral
TSE:XCX37Underperform
TSE:CNTR37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 49Neutral | CAD 420.72K | -0.14 | -610.58% | ― | ― | ― | |
| 37Underperform | CAD 258.28K | -1.03 | 5.55% | ― | ― | ― | |
| 37Underperform | CAD 579.89K | -2.13 | 13.65% | ― | ― | 36.39% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:XCX | Greenrise Global Brands Inc | 0.01 | -0.00 | -33.33% | |
| TSE:GHG | Global Hemp | 0.02 | 0.00 | 0.00% | |
| TSE:CNTR | Centr Brands Corp. | 0.05 | 0.00 | 0.00% | |
| TSE:XBRA | Xebra Brands Ltd. | 0.01 | 0.00 | 0.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Dec 30, 2025